Vaxcyte
PCVX
PCVX
250 hedge funds and large institutions have $8.13B invested in Vaxcyte in 2024 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 102 increasing their positions, 77 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 223 → 250 (+27)
0.97% more ownership
Funds ownership: 108.91% → 109.87% (+0.97%)
14% less funds holding in top 10
Funds holding in top 10: 14 → 12 (-2)
Holders
250
Holding in Top 10
12
Calls
$16.7M
Puts
$12.2M
Top Buyers
| 1 | +$158M | |
| 2 | +$148M | |
| 3 | +$140M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$87.8M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
+$84.7M |
Top Sellers
| 1 | -$39.9M | |
| 2 | -$33.1M | |
| 3 | -$33M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$22.6M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$19.6M |